US FDA approves Incyte's eczema treatment for pediatric patients
Incyte(US:INCY) Reutersยท2025-09-18 20:29Group 1 - The U.S. Food and Drug Administration has approved Incyte's eczema treatment for children aged between 2 and 11 years [1]
Incyte(US:INCY) Reutersยท2025-09-18 20:29